Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006
Authors
Long, GBlank, C
Ribas, A
Mortier, L
Carlino, M
Lotem, M
Lorigan, Paul C
Neyns, B
Petrella, T
Puzanov, I
Richtig, E
O’Day, S
Masucci, G
Lebbe, C
Steven, N
Lutzky, J
Hille, D
Ebbinghaus, S
Ibrahim, N
McNeil, C
Affiliation
Melanoma Institute Australia, Medical Oncology, SydneyIssue Date
2017-02
Metadata
Show full item recordCitation
Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006. 2017, 72:S122 Eur J CancerJournal
European Journal of CancerDOI
10.1016/S0959-8049(17)30482-3Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0959804917304823Type
Meetings and ProceedingsLanguage
enISSN
09598049ae974a485f413a2113503eed53cd6c53
10.1016/S0959-8049(17)30482-3